Canopy Clinical US Roadshow 2026
Accelerate your metabolic pipeline with Canopy Clinical - Meet us at ADA

Andrew Walker developed an early interest in patient care during his undergraduate studies in Psychology at the University of Nebraska, where he focused on mental health, depressive disorders, and substance addiction. He subsequently joined a neuroscience laboratory at the University of Nebraska, researching the neural circuits involved in addiction and anhedonia.
In 2011, Andrew relocated to Melbourne to undertake his PhD at The Florey Institute of Neuroscience and Mental Health (University of Melbourne). His doctoral research continued to explore reward‑seeking behaviour using pre‑clinical models to better understand the neural circuits underlying motivation and mental health.
Andrew transitioned into clinical research in 2017, beginning as a Clinical Research Coordinator at Nucleus Network and progressing into project management roles. Clinical research proved to be a natural fit, allowing him to maintain strong connections to scientific inquiry while directly contributing to patient‑focused, real‑world outcomes.
He has since worked as a Clinical Project Manager across both CRO and site environments, developing deep expertise and a strong passion for clinical site operations. This commitment to improving patient care ultimately led Andrew to his current role as Site Director at Canopy Clinical Altona North, where he finds it deeply rewarding to positively impact patient outcomes across Melbourne’s western suburbs.
Sometimes, numbers speak louder than words:
The Canopy Edge
Why Australia?
Australia is one of the leading destinations globally for companies looking to outsource their early phase clinical trials. There is a myriad of benefits in outsourcing early phase clinical trials to Australia, including:





